# Lack of association between G6PD variants and Parkinson disease

**Authors:** Leah V. Chifamba, Sitki Cem Parlar, Lang Liu, Leonard L. Sokol, Eric Yu, Farnaz Asayesh, Jamil Ahmad, Jennifer A. Ruskey, Dan Spiegelman, Cheryl Waters, Oury Monchi, Yves Dauvilliers, Nicolas Dupré, Alla Timofeeva, Anton Emelyanov, Sofya Pchelina, Irina Miliukhina, Lior Greenbaum, Sharon Hassin-Baer, Roy N. Alcalay, Alberto J. Espay, Ziv Gan-Or, Konstantin Senkevich

PMC · DOI: 10.1016/j.xhgg.2025.100555 · Human Genetics and Genomics Advances · 2025-12-09

## TL;DR

This study found no evidence that genetic variants in the G6PD gene are linked to an increased risk of Parkinson's disease.

## Contribution

The study provides new evidence refuting a potential role of G6PD gene variants in Parkinson disease risk.

## Key findings

- Common G6PD variants were not significantly associated with Parkinson disease in any cohort.
- Rare G6PD variants also showed no significant association with Parkinson disease risk.
- Results suggest G6PD is unlikely to play a major role in Parkinson disease.

## Abstract

Oxidative stress has been implicated in Parkinson disease (PD). Genes involved in PD, such as PRKN, PINK1, and PARK7, contribute to oxidative stress in dopaminergic neurons. The X-linked G6PD gene encodes glucose 6-phosphate dehydrogenase, an important regulator of oxidative stress. Recent studies suggested that alpha-synuclein aggregates may impair G6PD activity and contribute to dopaminergic neuron loss, and that G6PD mutations may independently increase the risk of PD. In this study, we aimed to examine the role of common and rare G6PD variants in PD across 6 cohorts, including 8,905 PD cases, 16,770 proxy cases, and 394,098 controls. These cohorts were analyzed after stratification by sex and then combined to account for the G6PD X-linked location. Using logistic regression, we did not identify significant associations for common variants in any of the cohorts. The optimized sequence Kernel association (SKAT-O) test was performed to assess the effect of rare variants (minor allele frequency <0.01) across six cohorts, followed by a meta-analysis using metaSKAT, also demonstrating lack of association. In conclusion, we did not find evidence for a role for G6PD in PD.

We investigated common and rare variants in the X-linked G6PD gene across six large cohorts of Parkinson disease patients and controls. Our results show no significant associations, suggesting G6PD is unlikely to play a major role in Parkinson disease risk.

## Linked entities

- **Genes:** G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539], PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071], PINK1 (PTEN induced kinase 1) [NCBI Gene 65018], PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315]
- **Diseases:** Parkinson disease (MONDO:0005180)

## Full-text entities

- **Genes:** PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}
- **Diseases:** PD (MESH:D010300)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12799763/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12799763/full.md

---
Source: https://tomesphere.com/paper/PMC12799763